Bajaj Healthcare reports no deviation in preferential issue proceeds utilisation
As filed · Bajaj Healthcare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
What happened
FactBajaj Healthcare stated that there was no deviation or variation in the utilisation of proceeds raised through the allotment of equity shares following conversion of convertible warrants. The statement for the quarter ended September 30, 2026 was reviewed by the Audit Committee.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
ContradictedGross profit for the quarter stood at INR80.4 crores, up by 16.2% year-on-year compared to INR69.1 crores in Q1 FY26.
Profit after tax from continuing operations stood at about INR13.9 crores, up by 14.1% year-on-year from INR12.2 crores in Q1 last year and broadly remaining stable versus INR13.8 crores in Q4, translating into a PAT margin from continuing operations of 8.4%.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
- We completed the construction of a plant with the capacity to process approximately 250 MT of opium gum and ab (management committed by FY29)
Evidence
- Bajaj Healthcare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- The filing confirms that the company’s stated use of preferential issue proceeds remained unchanged during the reported quarter.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%